Summary
The fund seeks long-term growth of capital through investing in large- and mega-size U.S. companies.
The investment starts with a list of companies included in the benchmark index, Research team with the help of quantitative techniques and financial screens separates companies with stable earnings, return on capital and business growth.
Next, the research team analyzes business models, identifies factors and conditions for the earnings and cash flow growth durability and estimates company valuations.
The fund fa
Link
Directors
Feb 13, 2024- Jorge A. Bermudez
- Garry L. Moody
- Jeanette W. Loeb
- Michael J. Downey
- Onur Erzan
- Nancy P. Jacklin
- Carol C. McMullen
- Marshall C. Turner, Jr.
Chief Compliance Officer
- Jennifer Friedland
Fund Manager(s)
- Frank Caruso
- Vinay Thapar
- John Fogarty
Price
Company Name |
Holding |
| Vertex Pharmaceuticals Inc | 3.01 % |
| Philip Morris International Inc | 2.34 % |
| UnitedHealth Group Inc | 2.21 % |
| EOG Resources Inc | 1.7 % |
| Ferguson PLC | 1.32 % |
| nVent Electric PLC | 1.25 % |
| DR Horton Inc | 0.91 % |
| Comcast Corp | 0.84 % |
| Genmab A/S | 0.76 % |
| Citigroup Inc | 0.69 % |
| More |
Documents
Performance
YTD
8.6%
3 Year
-16.27%
5 Year
4.13%
Best
38.55%
2003
Worst
-38.62%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 12.6% | 4.6% | -7.7% | -12.7% | -19.8% | 10.2% | -1.1% | 5.4% | -1.2% | 2.9% |
| Q2 | -4% | 5.5% | -14% | 31.3% | 18.4% | 2.7% | 4.9% | 3.6% | 0.2% | -0.6% |
| Q3 | - | -2.1% | -3.4% | -18.7% | -0.3% | 0.2% | 7.4% | 5.8% | 4.8% | -4.6% |
| Q4 | - | 5.7% | -4.8% | 8.9% | 12.5% | 2.7% | -12.4% | 4.8% | 3.3% | 7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.4% | 6.3% | 3.3% | -3.5% | - | - | - | - | - | - | - | - |
| 2023 | 5.5% | -2.7% | 1.8% | 1.4% | -1.5% | 5.6% | 2.7% | -0.8% | -4% | -1.3% | 8% | -2.2% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9% | 13% | -27% | 2% | 7% | 18% | -4% | 22% | 7% | 5% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ADGCX | 9% | 13% | -27% | 2% | 7% | 18% | -4% | 22% | 7% | 5% |
| Russell 3000 Index | - | - | -21% | 24% | 19% | 29% | -7% | 19% | 10% | -1% |
| Alpha | 9% | 13% | -6% | -23% | -12% | -10% | 3% | 3% | -3% | 6% |